{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:43Z","timestamp":1786979623481,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,2,28]],"date-time":"2010-02-28T00:00:00Z","timestamp":1267315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00115-010-2931-x","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T06:01:43Z","timestamp":1267164103000},"page":"409-417","source":"Crossref","is-referenced-by-count":11,"title":["HIV-assoziierte Neuropathien","HIV-associated neuropathies"],"prefix":"10.1007","volume":"81","author":[{"name":"Arendt G f\u00fcr die Deutsche Neuro-AIDS-Arbeitsgemeinschaft (DNAA)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.W.","family":"Husstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,28]]},"reference":[{"key":"2931_CR1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s001150050605","volume":"71","author":"Deutsche","year":"2000","unstructured":"Deutsche Neuro-AIDS-Arbeitsgemeinschaft DNAA (2000) Peripheral nerve diseases and myopathies associated with HIV infection. Nervenarzt 71:442\u2013450","journal-title":"Nervenarzt"},{"key":"2931_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","volume":"68","author":"Abrams","year":"2007","unstructured":"Abrams DI, Jay CA, Shade SB et al (2007) Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68:515\u2013521","journal-title":"Neurology"},{"key":"2931_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0163-4453(98)92982-6","volume":"36","author":"Anders","year":"1998","unstructured":"Anders HJ, Weiss N, Bogner JR, Goebel FD (1998) Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. J Infect 36:29\u201333","journal-title":"J Infect"},{"key":"2931_CR4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ana.410340616","volume":"34","author":"Apostolski","year":"1993","unstructured":"Apostolski S, McAlarney T, Quattrini A et al (1993) The gp120\u00a0glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann Neurol 34:855\u2013863","journal-title":"Ann Neurol"},{"key":"2931_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/08820139409063432","volume":"23","author":"Apostolski","year":"1994","unstructured":"Apostolski S, McAlarney T, Hays AP, Latov N (1994) Complement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1. Immunol Invest 23:47\u201352","journal-title":"Immunol Invest"},{"key":"2931_CR6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/(SICI)1097-4598(199809)21:9<1188::AID-MUS10>3.0.CO;2-O","volume":"21","author":"Bradley","year":"1998","unstructured":"Bradley WG, Shapshak P, Delgado S et al (1998) Morphometric analysis of the peripheral neuropathy of AIDS. Muscle Nerve 21:1188\u20131195","journal-title":"Muscle Nerve"},{"key":"2931_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-510X(02)00418-5","volume":"208","author":"Brannagan","year":"2003","unstructured":"Brannagan TH 3rd, Zhou Y (2003) HIV-associated Guillain-Barre syndrome. J Neurol Sci 208:39\u201342","journal-title":"J Neurol Sci"},{"key":"2931_CR8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archneur.58.10.1561","volume":"58","author":"Brinley","year":"2001","unstructured":"Brinley FJ Jr., Pardo CA, Verma A (2001) Human immunodeficiency virus and the peripheral nervous system workshop. Arch Neurol 58:1561\u20131566","journal-title":"Arch Neurol"},{"key":"2931_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-200207010-00002","volume":"30","author":"Cherry","year":"2002","unstructured":"Cherry CL, Gahan ME, McArthur JC et al (2002) Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J Acquir Immune Defic Syndr 30:271\u2013277","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2931_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410210107","volume":"21","author":"Cornblath","year":"1987","unstructured":"Cornblath DR, McArthur JC, Kennedy PG et al (1987) Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 21:32\u201340","journal-title":"Ann Neurol"},{"key":"2931_CR11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(87)93054-6","volume":"2","author":"Craddock","year":"1987","unstructured":"Craddock C, Pasvol G, Bull R et al (1987) Cardiorespiratory arrest and autonomic neuropathy in AIDS. Lancet 2:16\u201318","journal-title":"Lancet"},{"key":"2931_CR12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/labinvest.3780367","volume":"81","author":"Dalakas","year":"2001","unstructured":"Dalakas MC, Semino-Mora C, Leon-Monzon M (2001) Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2\u20193\u2019-dideoxycytidine (ddC). Lab Invest 81:1537\u20131544","journal-title":"Lab Invest"},{"key":"2931_CR13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0022-510X(93)90295-A","volume":"114","author":"Esiri","year":"1993","unstructured":"Esiri MM, Morris CS, Millard PR (1993) Sensory and sympathetic ganglia in HIV-1 infection: immunocytochemical demonstration of HIV-1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation. J Neurol Sci 114:178\u2013187","journal-title":"J Neurol Sci"},{"key":"2931_CR14","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/00126334-200412150-00010","volume":"37","author":"Estanislao","year":"2004","unstructured":"Estanislao L, Carter K, McArthur J et al (2004) A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr 37:1584\u20131586","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2931_CR15","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1371\/journal.pone.0000551","volume":"2","author":"Evans","year":"2007","unstructured":"Evans SR, Simpson DM, Kitch DW et al (2007) A randomized trial evaluating prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. PLoS ONE 2:e551","journal-title":"PLoS ONE"},{"key":"2931_CR16","first-page":"408","volume":"12","author":"Franco-Paredes","year":"2002","unstructured":"Franco-Paredes C, Rebolledo P, Folch E et al (2002) Diagnosis of diffuse CD8+ lymphocytosis syndrome in HIV-infected patients. AIDS Read 12:408\u2013413","journal-title":"AIDS Read"},{"key":"2931_CR17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0140-6736(90)90172-2","volume":"335","author":"Fuller","year":"1990","unstructured":"Fuller GN, Gill SK, Guiloff RJ et al (1990) Ganciclovir for lumbosacral polyradiculopathy in AIDS. Lancet 335:48\u201349","journal-title":"Lancet"},{"key":"2931_CR18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.50.4.1041","volume":"50","author":"Gherardi","year":"1998","unstructured":"Gherardi RK, Chretien F, Delfau-Larue MH et al (1998) Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology 50:1041\u20131044","journal-title":"Neurology"},{"key":"2931_CR19","first-page":"159","volume":"72","author":"Griffin","year":"1994","unstructured":"Griffin JW, Wesselingh SL, Griffin DE et al (1994) Peripheral nerve disorders in HIV infection. Similarities and contrasts with CNS disorders. Res Publ Assoc Res Nerv Ment Dis 72:159\u2013182","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"2931_CR20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00415-004-0529-6","volume":"251","author":"Hahn","year":"2004","unstructured":"Hahn K, Arendt G, Braun JS et al (2004) A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 251:1260\u20131266","journal-title":"J Neurol"},{"key":"2931_CR21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1212\/01.wnl.0000261245.36884.7c","volume":"68","author":"Hahn","year":"2007","unstructured":"Hahn K, Triolo A, Hauer P et al (2007) Impaired reinnervation in HIV infection following experimental denervation. Neurology 68:1251\u20131256","journal-title":"Neurology"},{"key":"2931_CR22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.expneurol.2007.06.015","volume":"210","author":"Hahn","year":"2008","unstructured":"Hahn K, Robinson B, Anderson C et al (2008) Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons. Exp Neurol 210:30\u201340","journal-title":"Exp Neurol"},{"key":"2931_CR23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.aids.0000180786.02930.a1","volume":"19","author":"Hulgan","year":"2005","unstructured":"Hulgan T, Haas DW, Haines JL et al (2005) Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19:1341\u20131349","journal-title":"AIDS"},{"key":"2931_CR24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(89)92085-0","volume":"2","author":"Itescu","year":"1989","unstructured":"Itescu S, Brancato LJ, Winchester R (1989) A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 2:466\u2013468","journal-title":"Lancet"},{"key":"2931_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.virol.2005.01.027","volume":"334","author":"Jones","year":"2005","unstructured":"Jones G, Zhu Y, Silva C et al (2005) Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation. Virology 334:178\u2013193","journal-title":"Virology"},{"key":"2931_CR26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00415-006-0262-4","volume":"253","author":"Katsarava","year":"2006","unstructured":"Katsarava Z, Yaldizli O, Voulkoudis C et al (2006) Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV. J Neurol 253:1581\u20131584","journal-title":"J Neurol"},{"key":"2931_CR27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00002030-199604000-00006","volume":"10","author":"Kazi","year":"1996","unstructured":"Kazi S, Cohen PR, Williams F et al (1996) The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. AIDS 10:385\u2013391","journal-title":"AIDS"},{"key":"2931_CR28","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0006-2952(91)90672-R","volume":"42","author":"Keilbaugh","year":"1991","unstructured":"Keilbaugh SA, Prusoff WH, Simpson MV (1991) The PC12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs. Biochem Pharmacol 42:R5\u2013R8","journal-title":"Biochem Pharmacol"},{"key":"2931_CR29","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-200211080-00002","volume":"16","author":"Keswani","year":"2002","unstructured":"Keswani SC, Pardo CA, Cherry CL et al (2002) HIV-associated sensory neuropathies. AIDS 16:2105\u20132117","journal-title":"AIDS"},{"key":"2931_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ana.10401","volume":"53","author":"Keswani","year":"2003","unstructured":"Keswani SC, Chander B, Hasan C et al (2003) FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann Neurol 53:57\u201364","journal-title":"Ann Neurol"},{"key":"2931_CR31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ana.10645","volume":"54","author":"Keswani","year":"2003","unstructured":"Keswani SC, Polley M, Pardo CA et al (2003) Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 54:287\u2013296","journal-title":"Ann Neurol"},{"key":"2931_CR32","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.51.6.1682","volume":"51","author":"Kieburtz","year":"1998","unstructured":"Kieburtz K, Simpson D, Yiannoutsos C et al (1998) A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS clinical trial group 242 protocol team. Neurology 51:1682\u20131688","journal-title":"Neurology"},{"key":"2931_CR33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mus.880170104","volume":"17","author":"Lange","year":"1994","unstructured":"Lange DJ (1994) AAEM minimonograph #41: neuromuscular diseases associated with HIV-1 infection. Muscle Nerve 17:16\u201330","journal-title":"Muscle Nerve"},{"key":"2931_CR34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/426076","volume":"40","author":"Lichtenstein","year":"2005","unstructured":"Lichtenstein KA, Armon C, Baron A et al (2005) Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 40:148\u2013157","journal-title":"Clin Infect Dis"},{"key":"2931_CR35","first-page":"242","volume":"84","author":"Lohmoller","year":"1989","unstructured":"Lohmoller G, Matuschke A, Goebel FD (1989) False-positive test of autonomic neuropathy in HIV infection and AIDS? Case control study of heart rate variability in 62 HIV positive patients. Med Klin 84:242\u2013245","journal-title":"Med Klin"},{"key":"2931_CR36","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1212\/WNL.54.11.2120","volume":"54","author":"Martin","year":"2000","unstructured":"Martin C, Solders G, Sonnerborg A, Hansson P (2000) Antiretroviral therapy may improve sensory function in HIV-infected patients: a pilot study. Neurology 54:2120\u20132127","journal-title":"Neurology"},{"key":"2931_CR37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1474-4422(05)70165-4","volume":"4","author":"McArthur","year":"2005","unstructured":"McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 4:543\u2013555","journal-title":"Lancet Neurol"},{"key":"2931_CR38","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1128\/AAC.38.8.1824","volume":"38","author":"Medina","year":"1994","unstructured":"Medina DJ, Tsai CH, Hsiung GD, Cheng YC (1994) Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides. Antimicrob Agents Chemother 38:1824\u20131828","journal-title":"Antimicrob Agents Chemother"},{"key":"2931_CR39","unstructured":"Melli GaHA (2005) In vitro models of HIV-associated neuropathies differ in pathogenic site of action. 12th conference on retroviruses and opportunistic infections"},{"key":"2931_CR40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/WNL.40.4.569","volume":"40","author":"Miller","year":"1990","unstructured":"Miller RG, Storey JR, Greco CM (1990) Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 40:569\u2013574","journal-title":"Neurology"},{"key":"2931_CR41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archneur.61.4.546","volume":"61","author":"Morgello","year":"2004","unstructured":"Morgello S, Estanislao L, Simpson D et al (2004) HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol 61:546\u2013551","journal-title":"Arch Neurol"},{"key":"2931_CR42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ana.410410406","volume":"41","author":"Moulignier","year":"1997","unstructured":"Moulignier A, Authier FJ, Baudrimont M et al (1997) Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 41:438\u2013445","journal-title":"Ann Neurol"},{"key":"2931_CR43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0885-3924(99)00139-6","volume":"19","author":"Paice","year":"2000","unstructured":"Paice JA, Ferrans CE, Lashley FR et al (2000) Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage 19:45\u201352","journal-title":"J Pain Symptom Manage"},{"key":"2931_CR44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1529-8027.2001.006001021.x","volume":"6","author":"Pardo","year":"2001","unstructured":"Pardo CA, McArthur JC, Griffin JW (2001) HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 6:21\u201327","journal-title":"J Peripher Nerv Syst"},{"key":"2931_CR45","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.20816","volume":"59","author":"Pettersen","year":"2006","unstructured":"Pettersen JA, Jones G, Worthington C et al (2006) Sensory neuropathy in human immunodeficiency virus\/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol 59:816\u2013824","journal-title":"Ann Neurol"},{"key":"2931_CR46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.58.1.115","volume":"58","author":"Polydefkis","year":"2002","unstructured":"Polydefkis M, Yiannoutsos CT, Cohen BA et al (2002) Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58:115\u2013119","journal-title":"Neurology"},{"key":"2931_CR47","doi-asserted-by":"crossref","unstructured":"Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8 [Suppl 2]:115\u2013121","DOI":"10.1080\/13550280290101094"},{"key":"2931_CR48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(89)90091-3","volume":"1","author":"Schielke","year":"1989","unstructured":"Schielke E, Pfister HW, Einhaupl KM (1989) Peripheral facial nerve palsy associated with HIV infection. Lancet 1:553\u2013554","journal-title":"Lancet"},{"key":"2931_CR49","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1212\/WNL.58.12.1764","volume":"58","author":"Schifitto","year":"2002","unstructured":"Schifitto G, McDermott MP, McArthur JC et al (2002) Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 58:1764\u20131768","journal-title":"Neurology"},{"key":"2931_CR50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/01.WNL.0000152981.32057.BB","volume":"64","author":"Schifitto","year":"2005","unstructured":"Schifitto G, McDermott MP, McArthur JC et al (2005) Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology 64:842\u2013848","journal-title":"Neurology"},{"key":"2931_CR51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/13550280600873835","volume":"12","author":"Schifitto","year":"2006","unstructured":"Schifitto G, Yiannoutsos CT, Simpson DM et al (2006) A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol 12:328\u2013331","journal-title":"J Neurovirol"},{"key":"2931_CR52","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/WNL.47.5.1254","volume":"47","author":"Simpson","year":"1996","unstructured":"Simpson DM, Dorfman D, Olney RK et al (1996) Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group. Neurology 47:1254\u20131259","journal-title":"Neurology"},{"key":"2931_CR53","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.WNL.0000063304.88470.D9","volume":"60","author":"Simpson","year":"2003","unstructured":"Simpson DM, McArthur JC, Olney R et al (2003) Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 60:1508\u20131514","journal-title":"Neurology"},{"key":"2931_CR54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneur.56.1.84","volume":"56","author":"Tagliati","year":"1999","unstructured":"Tagliati M, Grinnell J, Godbold J, Simpson DM (1999) Peripheral nerve function in HIV infection: clinical, electrophysiologic and laboratory findings. Arch Neurol 56:84\u201389","journal-title":"Arch Neurol"},{"key":"2931_CR55","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/WNL.41.6.812","volume":"41","author":"Thornton","year":"1991","unstructured":"Thornton CA, Latif AS, Emmanuel JC (1991) Guillain-Barre syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology 41:812\u2013815","journal-title":"Neurology"},{"key":"2931_CR56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1529-8027.2001.006001008.x","volume":"6","author":"Verma","year":"2001","unstructured":"Verma A (2001) Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst 6:8\u201313","journal-title":"J Peripher Nerv Syst"},{"key":"2931_CR57","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","volume":"67","author":"Wernicke","year":"2006","unstructured":"Wernicke JF, Pritchett YL, D\u2019Souza DN et al (2006) A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67:1411\u20131420","journal-title":"Neurology"},{"key":"2931_CR58","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2165\/00003495-200059060-00005","volume":"59","author":"Wulff","year":"2000","unstructured":"Wulff EA, Wang AK, Simpson DM (2000) HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 59:1251\u20131260","journal-title":"Drugs"},{"key":"2931_CR59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1468-1293.2007.00467.x","volume":"8","author":"Youle","year":"2007","unstructured":"Youle M, Osio M (2007) A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med 8:241\u2013250","journal-title":"HIV Med"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2931-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-010-2931-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2931-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:08:43Z","timestamp":1558573723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-010-2931-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,28]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["2931"],"URL":"https:\/\/doi.org\/10.1007\/s00115-010-2931-x","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,28]]}}}